|
Volumn 21, Issue 2, 2003, Pages 121-
|
US policy may encourage counterfeit drugs.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
ARTICLE;
BIOTECHNOLOGY;
DEVELOPING COUNTRY;
DRUG INDUSTRY;
DRUG LEGISLATION;
ECONOMICS;
LEGAL ASPECT;
MOTIVATION;
PATENT;
POLICY;
STANDARD;
UNITED STATES;
BIOTECHNOLOGY;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
DRUGS, GENERIC;
LEGISLATION, DRUG;
MOTIVATION;
PATENTS;
PUBLIC POLICY;
UNITED STATES;
|
EID: 0041786606
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|